Related Experiment Video
Updated: Jul 3, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Self-management of anticoagulation
1Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.m.levi@amc.uva.nl
Insights
Patients managing their own warfarin anticoagulation using portable INR devices achieve better therapeutic control and improved quality of life compared to standard care. This self-management approach enhances patient satisfaction and clinical outcomes.
Area of Science:
- Cardiology
- Hematology
- Patient Self-Management
Background:
- Vitamin K antagonist therapy, such as warfarin, necessitates frequent International Normalized Ratio (INR) monitoring and dose adjustments.
- Suboptimal anticoagulation control (30-50% of the time) and time-consuming clinic visits negatively impact patient satisfaction.
Purpose of the Study:
- To evaluate the efficacy and patient-reported outcomes of self-management of anticoagulation using portable coagulometers.
- To compare self-management with traditional care models provided by general practitioners, specialists, and specialized anticoagulation clinics.
Main Methods:
- Utilized portable coagulometers for self-measurement of INR from capillary blood.
- Patients self-adjusted warfarin dosage based on INR readings.
- Compared outcomes with standard anticoagulation management strategies.
Main Results:
- Self-management of INR and warfarin dosing led to superior anticoagulation control compared to general practitioner or specialist care.
- Anticoagulation control in self-managing patients was comparable to that achieved in specialized anticoagulation clinics.
- Patients engaged in self-management reported significant improvements in treatment satisfaction and quality of life.
Conclusions:
- Portable coagulometers empower patients to effectively self-manage warfarin therapy.
- Anticoagulation self-management offers a viable and beneficial alternative to traditional care, improving both clinical control and patient well-being.
Abstract:
Treatment with vitamin K antagonists (i.e., warfarin or coumadin derivatives) requires repeated monitoring of the intensity of anticoagulation and regular dose adjustment. Nevertheless, many patients are not in the therapeutic target range for a considerable proportion (30-50%) of the time. In addition, repeated laboratory checks and visits to the (anticoagulation) clinic or office are time-consuming and may have a negative impact on patient satisfaction. Recently, reliable portable coagulometers have become available and these devices allow the measurement of the international normalized ratio (INR) from a small drop of capillary blood, thereby enabling patients to self-manage their anticoagulation. Clinical studies show that self-testing of the INR and self-adjusting of the warfarin dose results in a better control of anticoagulation in comparison with regular care by general practitioners or specialists and is at least as good as management by a specialized anticoagulation clinic. Moreover, treatment-related patient satisfaction and quality of life improves in patients performing self-management of anticoagulation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Atherosclerosis III: Management
Pulmonary Embolism III: Nursing Management